Clinical Trial Update: KRN7000 in Treating Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating KRN7000 for solid tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Solid Tumors

Drugs mentioned

• KRN7000 (alpha-galactosylceramide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: WITHDRAWN